The purpose of this proposal is to demonstrate the capabilities of the University of Pittsburgh in continuing to participate in the Maternal-Fetal Medicine Units Network. Our Unit has been an active participant in the Network for the last nineteen years. During our tenure, which is the longest of all current or past MFMUs we have demonstrated our willingness to cooperate with other institutions and the NICHD in the development and implementation of clinical research protocols. We have been active participants in every aspect of Network activities. We have proposed protocols, have served on subcommittees of other protocols, have served on administrative subcommittees, have served as site visitors to evaluate other centers and have faithfully attended every one of the more than 80 Network meetings over the last nineteen years. We have effectively recruited patients and have provided intellectual input in the development of new projects as well as the implementation of protocols from our center and from others. The data provided by our unit have consistently been of the highest quality based on objective evaluation by the Data Coordinating Center. The Division of Maternal-Fetal Medicine is composed of 10 Maternal-Fetal Medicine specialists, four midwiyes, 6 research nurses, and three research associates who have committed in some way to the Network, either in the recruitment of patients, implementation of the studies at our site, patient evaluation, biological fluid collection, obtaining consent or development of protocols Eight research faculty in the Division are available to provide specialized expertise for Network projects. The obstetrical unit at the University of Pittsburgh is one of the largest private obstetrical service in the United States with over 8000 deliveries annually. In 2003, approximately 40% of our patients were considered as high risk prior to labor, Approximately 1800 women delivering at the University of Pittsburgh are indigent;1600 are black or Hispanic and 6500 are white, most of whom have third party insurance. The rates of smoking, obesity, drug abuse and hypertension at our center are among the highest in the Network. In previous trials the population at Magee proved unique. In both the low risk and high risk low dose aspirin studies, aspirin proved to be significantly better than placebo in preventing pre-eclampsia;ours was the only center where such a benefit was seen. These characteristics among our patients makes our institution particularly well suited for the performance of clinical trials and assures that results of Network studies are widely applicable across an entire spectrum of subjects. In this proposal we will: 1) describe our academic productivity and our contributions to the current Network, 2.) demonstrate the capabilities of our Unit, 3).provide evidence of our continuing commitment to the success of the Network of Maternal-Fetal Medicine Units and 4) propose a study for consideration by the Network. The relevance of the MFMU Network lies in its ability to perform relevant clinical research on pregnant women that could not otherwise be accomplished due to insufficient sample size. The Network has shown repeatedly that meaningful research can be performed with pregnant women and that that research can be undertaken safely.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Cooperative Clinical Research--Cooperative Agreements (U10)
Project #
5U10HD021410-25
Application #
7798213
Study Section
Special Emphasis Panel (ZHD1-MCHG-B (23))
Program Officer
Spong, Catherine
Project Start
1991-04-01
Project End
2011-03-31
Budget Start
2009-12-01
Budget End
2010-11-30
Support Year
25
Fiscal Year
2010
Total Cost
$247,442
Indirect Cost
Name
Magee-Women's Research Institute and Foundation
Department
Type
DUNS #
119132785
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Tita, Alan T N; Lai, Yinglei; Landon, Mark B et al. (2017) Predictive Characteristics of Elevated 1-Hour Glucose Challenge Test Results for Gestational Diabetes. Am J Perinatol 34:1464-1469
Chauhan, Suneet P; Rice, Madeline Murguia; Grobman, William A et al. (2017) Neonatal Morbidity of Small- and Large-for-Gestational-Age Neonates Born at Term in Uncomplicated Pregnancies. Obstet Gynecol 130:511-519
Casey, Brian M; Thom, Elizabeth A; Peaceman, Alan M et al. (2017) Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy. N Engl J Med 376:815-825
Yee, Lynn M; Costantine, Maged M; Rice, Madeline Murguia et al. (2017) Racial and Ethnic Differences in Utilization of Labor Management Strategies Intended to Reduce Cesarean Delivery Rates. Obstet Gynecol 130:1285-1294
Younge, Noelle; Goldstein, Ricki F; Bann, Carla M et al. (2017) Survival and Neurodevelopmental Outcomes among Periviable Infants. N Engl J Med 376:617-628
Silver, Robert M; Myatt, Leslie; Hauth, John C et al. (2017) Cell-Free Total and Fetal DNA in First Trimester Maternal Serum and Subsequent Development of Preeclampsia. Am J Perinatol 34:191-198
Blackwell, Sean C; Landon, Mark B; Mele, Lisa et al. (2016) Relationship Between Excessive Gestational Weight Gain and Neonatal Adiposity in Women With Mild Gestational Diabetes Mellitus. Obstet Gynecol 128:1325-1332
Hughes, Brenna L; Clifton, Rebecca G; Hauth, John C et al. (2016) Is Mid-trimester Insulin Resistance Predictive of Subsequent Puerperal Infection? A Secondary Analysis of Randomized Trial Data. Am J Perinatol 33:983-90
Bailit, Jennifer L; Grobman, William A; Rice, Madeline Murguia et al. (2016) Evaluation of delivery options for second-stage events. Am J Obstet Gynecol 214:638.e1-638.e10
Froehlich, Rosemary J; Sandoval, Grecio; Bailit, Jennifer L et al. (2016) Association of Recorded Estimated Fetal Weight and Cesarean Delivery in Attempted Vaginal Delivery at Term. Obstet Gynecol 128:487-94

Showing the most recent 10 out of 170 publications